Editas Medicine Stocks Decline After Missing Q2 Earnings Estimates
Editas Medicine Stocks Decline After Missing Q2 Earnings Estimates
Editas Medicine, Inc. EDIT registered a loss of 82 cents per share in the second quarter of 2024, which was wider than the Zacks Consensus Estimate of a loss of 69 cents. This marked a significant contrast from the loss of 56 cents per share reported in the year-ago quarter. The linchpin of the company’s ...











